vs

Side-by-side financial comparison of CITIZENS FINANCIAL SERVICES INC (CZFS) and Sol-Gel Technologies Ltd. (SLGL). Click either name above to swap in a different company.

CITIZENS FINANCIAL SERVICES INC is the larger business by last-quarter revenue ($29.6M vs $17.3M, roughly 1.7× Sol-Gel Technologies Ltd.). Sol-Gel Technologies Ltd. runs the higher net margin — 67.3% vs 35.4%, a 31.9% gap on every dollar of revenue. On growth, Sol-Gel Technologies Ltd. posted the faster year-over-year revenue change (217.7% vs 13.0%).

Citizens Financial Group, Inc. is an American bank holding company, headquartered in Providence, Rhode Island. The company owns the bank Citizens Bank, N.A., which operates in the U.S. states of Connecticut, Delaware, Florida, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island, Vermont, and Virginia, as well as Washington, DC.

Sol-Gel Technologies Ltd. is a specialty biopharmaceutical company focused on developing and commercializing innovative dermatology treatments. Leveraging its proprietary sol-gel delivery technology, it creates topical therapies for common skin conditions including acne, rosacea and atopic dermatitis, with primary markets across North America and Europe, partnering with established healthcare firms to expand product reach.

CZFS vs SLGL — Head-to-Head

Bigger by revenue
CZFS
CZFS
1.7× larger
CZFS
$29.6M
$17.3M
SLGL
Growing faster (revenue YoY)
SLGL
SLGL
+204.7% gap
SLGL
217.7%
13.0%
CZFS
Higher net margin
SLGL
SLGL
31.9% more per $
SLGL
67.3%
35.4%
CZFS

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CZFS
CZFS
SLGL
SLGL
Revenue
$29.6M
$17.3M
Net Profit
$10.5M
$11.6M
Gross Margin
Operating Margin
44.2%
65.1%
Net Margin
35.4%
67.3%
Revenue YoY
13.0%
217.7%
Net Profit YoY
31.3%
487.6%
EPS (diluted)
$2.17
$4.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CZFS
CZFS
SLGL
SLGL
Q4 25
$29.6M
Q3 25
$29.0M
Q2 25
$27.3M
$17.3M
Q1 25
$26.4M
Q4 24
$26.2M
Q3 24
$25.1M
Q2 24
$24.6M
$5.4M
Q1 24
$25.9M
Net Profit
CZFS
CZFS
SLGL
SLGL
Q4 25
$10.5M
Q3 25
$10.0M
Q2 25
$8.5M
$11.6M
Q1 25
$7.6M
Q4 24
$8.0M
Q3 24
$7.5M
Q2 24
$5.3M
$2.0M
Q1 24
$7.0M
Operating Margin
CZFS
CZFS
SLGL
SLGL
Q4 25
44.2%
Q3 25
42.6%
Q2 25
38.1%
65.1%
Q1 25
35.5%
Q4 24
37.2%
Q3 24
36.9%
Q2 24
25.9%
29.9%
Q1 24
32.8%
Net Margin
CZFS
CZFS
SLGL
SLGL
Q4 25
35.4%
Q3 25
34.5%
Q2 25
31.0%
67.3%
Q1 25
28.8%
Q4 24
30.5%
Q3 24
30.0%
Q2 24
21.4%
36.4%
Q1 24
27.1%
EPS (diluted)
CZFS
CZFS
SLGL
SLGL
Q4 25
$2.17
Q3 25
$2.09
Q2 25
$1.76
$4.17
Q1 25
$1.60
Q4 24
$1.64
Q3 24
$1.57
Q2 24
$1.10
$0.71
Q1 24
$1.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CZFS
CZFS
SLGL
SLGL
Cash + ST InvestmentsLiquidity on hand
$34.3M
$24.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$338.1M
$31.9M
Total Assets
$3.1B
$39.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CZFS
CZFS
SLGL
SLGL
Q4 25
$34.3M
Q3 25
$31.1M
Q2 25
$49.5M
$24.3M
Q1 25
$36.8M
Q4 24
$42.2M
Q3 24
$36.8M
Q2 24
$38.4M
$26.5M
Q1 24
$29.6M
Stockholders' Equity
CZFS
CZFS
SLGL
SLGL
Q4 25
$338.1M
Q3 25
$327.7M
Q2 25
$313.7M
$31.9M
Q1 25
$308.3M
Q4 24
$299.7M
Q3 24
$298.7M
Q2 24
$286.5M
$34.9M
Q1 24
$282.7M
Total Assets
CZFS
CZFS
SLGL
SLGL
Q4 25
$3.1B
Q3 25
$3.1B
Q2 25
$3.0B
$39.3M
Q1 25
$3.0B
Q4 24
$3.0B
Q3 24
$3.0B
Q2 24
$2.9B
$42.0M
Q1 24
$2.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CZFS
CZFS
SLGL
SLGL
Operating Cash FlowLast quarter
$36.5M
Free Cash FlowOCF − Capex
$35.2M
FCF MarginFCF / Revenue
119.0%
Capex IntensityCapex / Revenue
4.4%
Cash ConversionOCF / Net Profit
3.49×
TTM Free Cash FlowTrailing 4 quarters
$53.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CZFS
CZFS
SLGL
SLGL
Q4 25
$36.5M
Q3 25
$2.9M
Q2 25
$6.0M
Q1 25
$10.9M
Q4 24
$33.2M
Q3 24
$6.2M
Q2 24
$3.0M
Q1 24
$13.5M
Free Cash Flow
CZFS
CZFS
SLGL
SLGL
Q4 25
$35.2M
Q3 25
$2.7M
Q2 25
$5.5M
Q1 25
$10.4M
Q4 24
$31.9M
Q3 24
$5.6M
Q2 24
$2.9M
Q1 24
$13.4M
FCF Margin
CZFS
CZFS
SLGL
SLGL
Q4 25
119.0%
Q3 25
9.4%
Q2 25
20.1%
Q1 25
39.2%
Q4 24
121.6%
Q3 24
22.3%
Q2 24
11.8%
Q1 24
51.5%
Capex Intensity
CZFS
CZFS
SLGL
SLGL
Q4 25
4.4%
Q3 25
0.5%
Q2 25
1.8%
Q1 25
2.2%
Q4 24
5.0%
Q3 24
2.5%
Q2 24
0.5%
Q1 24
0.4%
Cash Conversion
CZFS
CZFS
SLGL
SLGL
Q4 25
3.49×
Q3 25
0.29×
Q2 25
0.71×
Q1 25
1.44×
Q4 24
4.16×
Q3 24
0.83×
Q2 24
0.57×
Q1 24
1.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons